UT San Antonio
UT Health San Antonio
210-567-7000 Give
Category ID
295

Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma

An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]

Share This Story

CNN: Genetic predisposition toward higher blood pressure, cholesterol may be linked to Alzheimer’s risk, study finds

Sudha Seshadri, MD, professor, Neurology, founding director, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this story.   Read More

Share This Story

Molecule shows potential to combat treatment resistance in brain tumor glioblastoma

Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]

Share This Story

San Antonio Business Journal: UT Health San Antonio pursuing billion-dollar plan to expand SA research

UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article.   Read Now

Share This Story

Think Science live Q&A to explore dementia in South Texas

Texas Public Radio will partner with UT Health San Antonio to serve the community at the next Think Science live program, sharing the latest information about the connections between brain and body health and new developments in the fight against dementia and Alzheimer’s disease.

Share This Story

Subscribe to Brain Health